C12N 2795/10222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2795/10222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 46 US grants and 62 published applications in this corpus.
Search patents in C12N- Granted patents
- 46
- Published applications
- 62
- Assignees
- 53
- Inventors
- 157
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 0 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 3 |
| 2016 | 1 | 4 |
| 2017 | 1 | 5 |
| 2018 | 4 | 4 |
| 2019 | 4 | 6 |
| 2020 | 6 | 4 |
| 2021 | 3 | 6 |
| 2022 | 2 | 2 |
| 2023 | 3 | 2 |
| 2024 | 2 | 6 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacteriophage, bacterial wilt disease control agent, and bacterial wilt disease control method14 Apr 2026US 12,599,142 B2Panefri Industrial Co., Ltd.
- Antibacterial composition and uses thereof22 Apr 2025US 12,280,080 B2Erytech Pharma
- Phage therapy of E coli infections16 Apr 2024US 11,957,724 B2Erytech Pharma
- Compositions of and methods for in vitro viral genome engineering27 Feb 2024US 11,913,032 B2C3J Therapeutics, Inc.
- Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles22 Aug 2023US 11,730,823 B2President and Fellows of Harvard College
- Methods and compositions for nucleic acid synthesis24 Sep 2026US 2026/0286415 A1Primrose Bio, Inc.
- Crop treatment16 Jul 2026US 2026/0198510 A1APS Biocontrol Limited
- Simultaneous production of structural proteins from heterologous bacteriophage in cell-free expression system2 Apr 2026US 2026/0092261 A1Technische Universität München
- Bacteria-targeting capsid particle, treatment composition, disinfectant, food, bacteria elimination method, bactericidal method, corrosion prevention method, animal treatment method, gene introduction method, bacteria function addition method, method for producing bacteria-targeting capsid particle, and method for producing nucleic acid for bacteria-targeting capsid particle25 Dec 2025US 2025/0387442 A1Jichi Medical University
- Bacteriophage, bacterial wilt disease control agent, and bacterial wilt disease control method12 Jun 2025US 2025/0185668 A1Panefri Industrial Co., Ltd.
Most cited
By later US patents
- Process for bacterial production of polypeptides19US 6,258,560 B1Genentech, Inc. · 2001
- Engineered enzymatically active bacteriophages and methods of uses thereof17US 8,182,804 B1Massachusetts Institute of Technology · 2012
- Process for bacterial production of polypeptides14US 6,180,367 B2Genentech, Inc. · 2001
- Phage therapy of pseudomonas infections6US 10,077,431 B2Pherecydes Pharma · 2018
- Enhanced production of toxic polypeptides in prokaryotes6US 5,843,703 ACalifornia Institute of Technology · 1998